Annual EBITDA:
-$54.87M-$6.40M(-13.20%)Summary
- As of today, CMPX annual EBITDA is -$54.87 million, with the most recent change of -$6.40 million (-13.20%) on December 31, 2024.
- During the last 3 years, CMPX annual EBITDA has risen by +$25.32 million (+31.57%).
- CMPX annual EBITDA is now -109.79% below its all-time high of -$26.16 million, reached on December 1, 2020.
Performance
CMPX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$20.70M-$3.10M(-17.59%)Summary
- As of today, CMPX quarterly EBITDA is -$20.70 million, with the most recent change of -$3.10 million (-17.59%) on June 30, 2025.
- Over the past year, CMPX quarterly EBITDA has dropped by -$6.12 million (-41.98%).
- CMPX quarterly EBITDA is now -343.99% below its all-time high of -$4.66 million, reached on June 1, 2021.
Performance
CMPX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$66.28M-$6.12M(-10.17%)Summary
- As of today, CMPX TTM EBITDA is -$66.28 million, with the most recent change of -$6.12 million (-10.17%) on June 30, 2025.
- Over the past year, CMPX TTM EBITDA has dropped by -$13.01 million (-24.43%).
- CMPX TTM EBITDA is now -558.37% below its all-time high of -$10.07 million, reached on March 1, 2019.
Performance
CMPX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CMPX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -13.2% | -42.0% | -24.4% |
| 3Y3 Years | +31.6% | -143.8% | -99.1% |
| 5Y5 Years | -75.3% | -343.2% | -171.2% |
CMPX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -38.0% | +31.6% | -124.3% | at low | -66.8% | at low |
| 5Y | 5-Year | -109.8% | +31.6% | -344.0% | at low | -177.2% | at low |
| All-Time | All-Time | -109.8% | +31.6% | -344.0% | at low | -558.4% | at low |
CMPX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$20.70M(-17.6%) | -$66.28M(-10.2%) |
| Mar 2025 | - | -$17.60M(-8.6%) | -$60.16M(-9.7%) |
| Dec 2024 | -$54.87M(-13.2%) | -$16.21M(-37.7%) | -$54.87M(-2.4%) |
| Sep 2024 | - | -$11.77M(+19.2%) | -$53.59M(-0.6%) |
| Jun 2024 | - | -$14.58M(-18.5%) | -$53.27M(-3.3%) |
| Mar 2024 | - | -$12.31M(+17.5%) | -$51.55M(-6.3%) |
| Dec 2023 | -$48.47M(-21.9%) | -$14.93M(-30.2%) | -$48.48M(-5.5%) |
| Sep 2023 | - | -$11.46M(+10.9%) | -$45.96M(+1.4%) |
| Jun 2023 | - | -$12.86M(-39.3%) | -$46.61M(-10.4%) |
| Mar 2023 | - | -$9.23M(+25.6%) | -$42.23M(-6.2%) |
| Dec 2022 | -$39.75M(+50.4%) | -$12.40M(-2.4%) | -$39.75M(+0.5%) |
| Sep 2022 | - | -$12.11M(-42.7%) | -$39.95M(-20.0%) |
| Jun 2022 | - | -$8.49M(-25.8%) | -$33.29M(-13.0%) |
| Mar 2022 | - | -$6.75M | -$29.46M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$80.19M(-206.6%) | - | - |
| Dec 2021 | - | -$12.61M(-131.4%) | -$29.64M(-23.9%) |
| Sep 2021 | - | -$5.45M(-16.9%) | -$23.92M(+11.4%) |
| Jun 2021 | - | -$4.66M(+32.7%) | -$27.00M(+0.0%) |
| Mar 2021 | - | -$6.93M(-0.7%) | -$27.00M(-6.1%) |
| Dec 2020 | -$26.16M(+16.4%) | -$6.88M(+19.3%) | -$25.45M(-4.1%) |
| Sep 2020 | - | -$8.53M(-82.6%) | -$24.45M(-2.7%) |
| Jun 2020 | - | -$4.67M(+13.0%) | -$23.80M(+12.8%) |
| Mar 2020 | - | -$5.37M(+8.7%) | -$27.31M(+14.7%) |
| Dec 2019 | -$31.30M(+11.8%) | -$5.88M(+25.4%) | -$32.01M(-22.5%) |
| Sep 2019 | - | -$7.88M(+3.5%) | -$26.13M(-43.2%) |
| Jun 2019 | - | -$8.17M(+18.8%) | -$18.24M(-81.2%) |
| Mar 2019 | - | -$10.07M | -$10.07M |
| Dec 2018 | -$35.49M | - | - |
FAQ
- What is Compass Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Compass Therapeutics, Inc.?
- What is Compass Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Compass Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Compass Therapeutics, Inc.?
- What is Compass Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Compass Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Compass Therapeutics, Inc.?
- What is Compass Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Compass Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of CMPX is -$54.87M
What is the all-time high annual EBITDA for Compass Therapeutics, Inc.?
Compass Therapeutics, Inc. all-time high annual EBITDA is -$26.16M
What is Compass Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, CMPX annual EBITDA has changed by -$6.40M (-13.20%)
What is Compass Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of CMPX is -$20.70M
What is the all-time high quarterly EBITDA for Compass Therapeutics, Inc.?
Compass Therapeutics, Inc. all-time high quarterly EBITDA is -$4.66M
What is Compass Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, CMPX quarterly EBITDA has changed by -$6.12M (-41.98%)
What is Compass Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of CMPX is -$66.28M
What is the all-time high TTM EBITDA for Compass Therapeutics, Inc.?
Compass Therapeutics, Inc. all-time high TTM EBITDA is -$10.07M
What is Compass Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, CMPX TTM EBITDA has changed by -$13.01M (-24.43%)